Cite
ChemInform Abstract: Discovery of Orally Active Anticancer Candidate CFI-400945 Derived from Biologically Promising Spirooxindoles: Success and Challenges.
MLA
Yu, Bin, et al. “ChemInform Abstract: Discovery of Orally Active Anticancer Candidate CFI-400945 Derived from Biologically Promising Spirooxindoles: Success and Challenges.” ChemInform, vol. 46, no. 23, June 2015, p. no. EBSCOhost, https://doi.org/10.1002/chin.201523292.
APA
Yu, B., Yu, Z., Qi, P., Yu, D., & Liu, H. (2015). ChemInform Abstract: Discovery of Orally Active Anticancer Candidate CFI-400945 Derived from Biologically Promising Spirooxindoles: Success and Challenges. ChemInform, 46(23), no. https://doi.org/10.1002/chin.201523292
Chicago
Yu, Bin, Zhiqiang Yu, Ping‐Ping Qi, De‐Quan Yu, and Hong‐Min Liu. 2015. “ChemInform Abstract: Discovery of Orally Active Anticancer Candidate CFI-400945 Derived from Biologically Promising Spirooxindoles: Success and Challenges.” ChemInform 46 (23): no. doi:10.1002/chin.201523292.